Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

C. AND SUBSIDIARIES

Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

(Unaudited)

Three Months Ended

September 30,

2007 2006

GAAP NET INCOME (LOSS) $(306,763) $95,741

Sales adjustments - (13,273)(6)

Cost of sales adjustments 22,255 (1) 20,804 (1)

Research and development adjustments 15,000 (2) - (8)

Selling, general and administrative

adjustments - 2,000 (7) (8)

Settlement reserve 369,000 (3) -

Gain on extinguishment of debt (5,319)(4) -

Income taxes (21,693)(5) (1,278)(5) (8)

379,243 8,253

ADJUSTED NET INCOME $72,480 $103,994

BASIC ADJUSTED INCOME PER COMMON SHARE $1.08 $1.71

DILUTED ADJUSTED INCOME PER COMMON SHARE $0.92 $1.55

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING 66,931 60,762

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING-ASSUMING DILUTION 79,030 67,072 Notes to Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

(1) To exclude the on-going amortization of acquired intangible assets.

(2) To exclude the recognition of a milestone related to the FDA's

acceptance of our NDA filing for TREANDA(R) (bendamustine HCl).

(3) To exclude the additional reserve established for the agreement in

principle reached with the U.S. Attorney's Office in Philadelphia.

(
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by Instrument (Liquid ... Valves, Guages, Seals), Accessories, Services, End User (Biotechnology, ... provides a detailed overview of the major drivers, ... impacting the preparative and process chromatography market along ...
(Date:12/24/2014)... 23, 2014 Earlier this year in a ... of the Adult Stem Cell Technology Center, LLC ( ASCTC ... unique property of adult tissue stem cells. His title ... Important for the Future,” embodied the essence of his message ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... Janesville, Wis. MobilePro Corp. announced today ... acquire Ticon.net , a Janesville-based Internet services provider. ... subscribers, $2 million in annualized revenue and to be ... to the signing of definitive agreements and customary closing ...
... of crap from the academic community for the theory he ... To summarize, Dr. Florida says that a citys predisposition for ... , ,Some of Richs indexes are controversial. For example, Rich ... more likely the city is to be economically successful. Richs ...
... ones. They start with a glorious vision: Suns out, tops down, ... And then theres a revenue shortfall, or a revolt by some ... doesnt matter so much as the fact that the project seems ... call the tow truck , ,Youve suddenly realized your project ...
Cached Biology Technology:The Creative Class from my perspective 2Technology in the ditch 2Technology in the ditch 3
(Date:1/22/2015)... 2015 Technology Showcase, Hall E -   EyeLock Inc. ... announced it will showcase its EyeLock ID technology integrated in ... of Energy,s Oak Ridge National Laboratory (ORNL) at ... iris identity authentication technology is being used to validate the ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
(Date:1/22/2015)... YORK and POINT ROBERTS, Washington ... news source covering leading sectors including technology and tech stocks, ... Privacy marketplace featuring master pickpocket and security consultant Apollo ... is stolen and talks about the Wocket™ biometric smart wallet, ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... vegetables? Your answer tells a lot about you. Now, ... have answered that question likely reveals a lot about you ... University of Rochester Medical Center, worms that are hermaphrodites (with ... smell, while the males the other of the two ...
... on Osteoporosis 2008 (IOF WCO), to be held in ... from special early bird rates. The IOF WCO 2008, ... the worlds largest scientific congress devoted specifically to osteoporosis. ... Non-Members and Students or Fellows, with a reduced registration ...
... SINGAPORE -- Two common dietary molecules found in ... harmful effects of radiation, researchers from the University ... protected both human skin cells and a skin ... radiation, the damaging radiation found in sunlight, the ...
Cached Biology News:Worms take the sniff test to reveal sex differences in brain 2Worms take the sniff test to reveal sex differences in brain 3Antioxidants could provide all-purpose radiation protection 2Antioxidants could provide all-purpose radiation protection 3
...
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
Antibody Diluent for IHC 125 ml...
QPRT Antibody...
Biology Products: